The National Institute on Aging and the Alzheimer’s Association (NIA-AA) draft diagnostic criteria on diagnosing Alzheimer’s disease issued at the 2023 AAIC Conference in Amsterdam, NL, have now been updated. The criteria address diagnosing, via biomarkers, Alzheimer's disease in adults, including Down syndrome. To see an Explainer. The updated version has been published in Alzheimer's & Dementia; it was originally released at the Clinical Trials on Alzheimer's Disease (CTAD) conference in October 2023. Comments on Down syndrome were included in the new iteration. (To see Nov. 16th submission.) The new Lumind/NTG Project will examine the concordance of the criteria applications for adults with Down syndrome to the new AA Criteria.
Go to LuMind IDSC website
